1. Home
  2. AVBH vs ALDX Comparison

AVBH vs ALDX Comparison

Compare AVBH & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBH
  • ALDX
  • Stock Information
  • Founded
  • AVBH 2003
  • ALDX 2004
  • Country
  • AVBH United States
  • ALDX United States
  • Employees
  • AVBH N/A
  • ALDX N/A
  • Industry
  • AVBH
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVBH
  • ALDX Health Care
  • Exchange
  • AVBH Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • AVBH 273.7M
  • ALDX 326.6M
  • IPO Year
  • AVBH N/A
  • ALDX 2014
  • Fundamental
  • Price
  • AVBH $25.05
  • ALDX $5.56
  • Analyst Decision
  • AVBH Strong Buy
  • ALDX Strong Buy
  • Analyst Count
  • AVBH 4
  • ALDX 2
  • Target Price
  • AVBH $28.38
  • ALDX $9.50
  • AVG Volume (30 Days)
  • AVBH 67.4K
  • ALDX 823.0K
  • Earning Date
  • AVBH 08-25-2025
  • ALDX 11-06-2025
  • Dividend Yield
  • AVBH N/A
  • ALDX N/A
  • EPS Growth
  • AVBH 61.05
  • ALDX N/A
  • EPS
  • AVBH 3.07
  • ALDX N/A
  • Revenue
  • AVBH $82,088,000.00
  • ALDX N/A
  • Revenue This Year
  • AVBH $15.40
  • ALDX N/A
  • Revenue Next Year
  • AVBH $16.94
  • ALDX $43.00
  • P/E Ratio
  • AVBH $8.17
  • ALDX N/A
  • Revenue Growth
  • AVBH 21.72
  • ALDX N/A
  • 52 Week Low
  • AVBH $19.32
  • ALDX $1.14
  • 52 Week High
  • AVBH $26.59
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • AVBH N/A
  • ALDX 53.64
  • Support Level
  • AVBH N/A
  • ALDX $5.69
  • Resistance Level
  • AVBH N/A
  • ALDX $5.93
  • Average True Range (ATR)
  • AVBH 0.00
  • ALDX 0.28
  • MACD
  • AVBH 0.00
  • ALDX -0.06
  • Stochastic Oscillator
  • AVBH 0.00
  • ALDX 26.35

About AVBH Avidbank Holdings Inc. Common stock

Avidbank Holdings Inc is a full-service commercial bank. It offers various services such as commercial and industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, real estate construction, and commercial real estate lending.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: